Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sham-Controlled Rapid-Acting Neuromodulation for Depression

NCT: NCT07487454 · NOT_YET_RECRUITING

NCT IDNCT07487454
StatusNOT_YET_RECRUITING
Start Date2026-12
Completion2028-05
SponsorUniversity of California, Davis (OTHER)
First posted
Last updated

Brief Summary

The goal of this study is to learn whether 5 days of accelerated intermittent theta burst stimulation (iTBS), a rapid form of transcranial magnetic stimulation (TMS), which is a non-invasive procedure that uses magnetic fields to stimulate brain activity, works to treat depression in adults. The main questions it aims to answer are: * Does accelerated iTBS reduce depressive symptoms compared to sham (placebo) stimulation? * Are there measurable brain, biological, and digitally measured emotion changes associated with treatment response? Participants will: * Be randomly assigned to receive either active iTBS or sham stimulation * Receive 10 stimulation sessions per day for 5 consecutive days (total of 50 sessions) * Complete MRI brain scans and EEG recordings before and after treatment * Provide blood and saliva samples to measure biological markers * Complete depression rating scales and questionnaires at baseline, during treatment, and at follow-up visits * Use a secure mobile app to record brief facial and vocal samples during the 5-day treatment and at follow-up visits * Return for follow-up visits at 1 week and at 1, 3, 6, and 12 months after treatment

Frequently Asked Questions

What is Sham-Controlled Rapid-Acting Neuromodulation for Depression?

Sham-Controlled Rapid-Acting Neuromodulation for Depression is a clinical trial registered under NCT07487454. Current status: NOT_YET_RECRUITING.

What is the status of NCT07487454?

The current status of NCT07487454 (Sham-Controlled Rapid-Acting Neuromodulation for Depression) is: NOT_YET_RECRUITING.

When did Sham-Controlled Rapid-Acting Neuromodulation for Depression start?

Sham-Controlled Rapid-Acting Neuromodulation for Depression started on 2026-12.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.